PSYCHEDELICS TO THERAPEUTICS Trademark

Trademark Overview

On Monday, November 1, 2021, a trademark application was filed for PSYCHEDELICS TO THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the PSYCHEDELICS TO THERAPEUTICS trademark a serial number of 97102763. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Tuesday, March 25, 2025. This trademark is owned by Cybin Corp.. The PSYCHEDELICS TO THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Pharmaceutical drug development services
psychedelics to therapeutics

General Information

Serial Number97102763
Word MarkPSYCHEDELICS TO THERAPEUTICS
Filing DateMonday, November 1, 2021
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateTuesday, March 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 15, 2025

Trademark Statements

Goods and ServicesPharmaceutical drug development services

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, November 12, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCybin Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressToronto, Ontario M5X1C9
CA

Trademark Events

Event DateEvent Description
Monday, February 14, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 4, 2021NEW APPLICATION ENTERED
Friday, November 12, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, February 3, 2022ASSIGNED TO EXAMINER
Monday, February 14, 2022NON-FINAL ACTION E-MAILED
Sunday, March 6, 2022EXAMINERS AMENDMENT E-MAILED
Monday, February 14, 2022NON-FINAL ACTION WRITTEN
Sunday, March 6, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Saturday, October 8, 2022REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Friday, December 22, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Thursday, January 25, 2024REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sunday, March 6, 2022EXAMINERS AMENDMENT -WRITTEN
Sunday, March 6, 2022EXAMINER'S AMENDMENT ENTERED
Monday, March 7, 2022LETTER OF SUSPENSION E-MAILED
Monday, March 7, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, March 7, 2022SUSPENSION LETTER WRITTEN
Wednesday, September 7, 2022SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Friday, April 14, 2023SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Saturday, April 15, 2023REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Thursday, November 14, 2024TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Friday, December 13, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, December 13, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 18, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 9, 2025NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, January 30, 2025ASSIGNED TO EXAMINER
Saturday, December 14, 2024ASSIGNED TO LIE

Related Keywords

therapeutics psychedelics services development drug pharmaceutical